These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22536298)

  • 1. Fuzzy modeling and control of HIV infection.
    Zarei H; Kamyad AV; Heydari AA
    Comput Math Methods Med; 2012; 2012():893474. PubMed ID: 22536298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal HIV treatment by maximising immune response.
    Culshaw RV; Ruan S; Spiteri RJ
    J Math Biol; 2004 May; 48(5):545-62. PubMed ID: 15133623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of HIV/AIDS infection system with drug dosages design via robust H(∞) fuzzy controller.
    Assawinchaichote W
    Biomed Mater Eng; 2015; 26 Suppl 1():S1945-51. PubMed ID: 26405968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
    Forde J; Volpe JM; Ciupe SM
    Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic CD4
    Sanchez-Martinez A; Perdomo-Celis F; Acevedo-Saenz L; Rugeles MT; Velilla PA
    J Clin Virol; 2019 Oct; 119():17-23. PubMed ID: 31445411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus.
    Rouzine IM; Sergeev RA; Glushtsov AI
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):666-71. PubMed ID: 16407101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral dynamics model with CTL immune response incorporating antiretroviral therapy.
    Wang Y; Zhou Y; Brauer F; Heffernan JM
    J Math Biol; 2013 Oct; 67(4):901-34. PubMed ID: 22930342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
    Piconi S; Parisotto S; Rizzardini G; Passerini S; Terzi R; Argenteri B; Meraviglia P; Capetti A; Biasin M; Trabattoni D; Clerici M
    Blood; 2011 Sep; 118(12):3263-72. PubMed ID: 21576701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
    Wang Y; Zhang Y; Tang T; Zhao W; Fu S; Zhang Z; Fu Y; Xu J; Ding H; Han X; Jiang Y
    Virology; 2020 Nov; 550():89-98. PubMed ID: 32920454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?
    Smith RJ; Schwartz EJ
    Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1.
    Wu Y; Zhang M; Wu J; Zhao X; Xia L
    J Math Biol; 2012 Feb; 64(3):495-512. PubMed ID: 21503727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal control of the chemotherapy of HIV.
    Kirschner D; Lenhart S; Serbin S
    J Math Biol; 1997 Aug; 35(7):775-92. PubMed ID: 9269736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
    Poizot-Martin I; Faucher O; Obry-Roguet V; Nicolino-Brunet C; Ronot-Bregigeon S; Dignat-George F; Tamalet C
    J Clin Virol; 2013 Aug; 57(4):351-5. PubMed ID: 23664725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
    Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
    PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal control of HIV dynamic using embedding method.
    Zarei H; Kamyad AV; Farahi MH
    Comput Math Methods Med; 2011; 2011():674318. PubMed ID: 21687584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the viral reservoir of latently infected CD4(+) T cells be eradicated with antiretroviral HIV drugs?
    Smith RJ; Aggarwala BD
    J Math Biol; 2009 Nov; 59(5):697-715. PubMed ID: 19165438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.